Literature DB >> 9446656

Development of autologous, oligoclonal, poorly functioning T lymphocytes in a patient with autosomal recessive severe combined immunodeficiency caused by defects of the Jak3 tyrosine kinase.

D Brugnoni1, L D Notarangelo, A Sottini, P Airò, M Pennacchio, E Mazzolari, S Signorini, F Candotti, A Villa, P Mella, P Vezzoni, R Cattaneo, A G Ugazio, L Imberti.   

Abstract

Defects of the common gamma chain subunit of the cytokine receptors (gamma c) or of Jak3, a tyrosine kinase required for gamma c signal transduction, result in T-B+ severe combined immunodeficiency (SCID). However, atypical cases, characterized by progressive development of T lymphocytes, have been also reported. We describe a child with SCID caused by Jak3 gene defects, which strongly but not completely affect Jak3 protein expression and function, who developed a substantial number (> 3,000/microL) of autologous CD3+CD4+ T cells. These cells showed a primed/activated phenotype (CD45R0+ Fas+ HLA-DR+ CD62L(lo)), defective secretion of T-helper 1 and T-helper 2 cytokines, reduced proliferation to mitogens, and a high in vitro susceptibility to spontaneous (caused by downregulation of bcl-2 expression) as well as activation-induced cell death. A restricted T-cell receptor repertoire was observed, with oligoclonal expansion within each of the dominant segments. These features resemble those observed in gamma c-/y and in Jak3-/- mice, in which a population of activated, anergic T cells (predominantly CD4+) also develops with age. These results suggest that residual Jak3 expression and function or other Jak3-independent signals may also permit the generation of CD4+ T cells that undergo in vivo clonal expansion in humans; however, these mechanisms do not allow development of CD8+ T cells, nor do they fully restore the functional properties of CD4+ T lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9446656

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  11 in total

Review 1.  Therapeutic targeting of Janus kinases.

Authors:  Marko Pesu; Arian Laurence; Nandini Kishore; Samuel H Zwillich; Gary Chan; John J O'Shea
Journal:  Immunol Rev       Date:  2008-06       Impact factor: 12.988

Review 2.  Severe combined immune deficiencies due to defects of the common gamma chain-JAK3 signaling pathway.

Authors:  F Candotti; J J O'Shea; A Villa
Journal:  Springer Semin Immunopathol       Date:  1998

Review 3.  The arrival of JAK inhibitors: advancing the treatment of immune and hematologic disorders.

Authors:  Yasuko Furumoto; Massimo Gadina
Journal:  BioDrugs       Date:  2013-10       Impact factor: 5.807

Review 4.  Inborn errors of human JAKs and STATs.

Authors:  Jean-Laurent Casanova; Steven M Holland; Luigi D Notarangelo
Journal:  Immunity       Date:  2012-04-20       Impact factor: 31.745

5.  Hypomorphic Janus kinase 3 mutations result in a spectrum of immune defects, including partial maternal T-cell engraftment.

Authors:  Federica Cattaneo; Mike Recher; Stefania Masneri; Sachin N Baxi; Claudia Fiorini; Francesca Antonelli; Christian A Wysocki; Jose G Calderon; Hermann Eibel; Angela R Smith; Francisco A Bonilla; Erdyni Tsitsikov; Silvia Giliani; Luigi D Notarangelo; Sung-Yun Pai
Journal:  J Allergy Clin Immunol       Date:  2013-02-04       Impact factor: 10.793

Review 6.  Small molecules to the rescue: Inhibition of cytokine signaling in immune-mediated diseases.

Authors:  Massimo Gadina; Nathalia Gazaniga; Laura Vian; Yasuko Furumoto
Journal:  J Autoimmun       Date:  2017-07-01       Impact factor: 7.094

7.  A case of aberrant CD8 T cell-restricted IL-7 signaling with a Janus kinase 3 defect-associated atypical severe combined immunodeficiency.

Authors:  Aaruni Khanolkar; Jeffrey D Wilks; Guorong Liu; Bridget M Simpson; Edward A Caparelli; Dawn A Kirschmann; Jenna Bergerson; Ramsay L Fuleihan
Journal:  Immunol Res       Date:  2020-02       Impact factor: 2.829

8.  JAK Kinases in Health and Disease: An Update.

Authors:  Arian Laurence; Marko Pesu; Olli Silvennoinen; John O'Shea
Journal:  Open Rheumatol J       Date:  2012-09-07

Review 9.  Janus kinases and signal transducers and activators of transcription: their roles in cytokine signaling, development and immunoregulation.

Authors:  R A Ortmann; T Cheng; R Visconti; D M Frucht; J J O'Shea
Journal:  Arthritis Res       Date:  1999-12-23

10.  Combined immunodeficiency evolving into predominant CD4+ lymphopenia caused by somatic chimerism in JAK3.

Authors:  Sol A Ban; Elisabeth Salzer; Martha M Eibl; Angela Linder; Christoph B Geier; Elisangela Santos-Valente; Wojciech Garncarz; Thomas Lion; Raphael Ott; Christoph Seelbach; Kaan Boztug; Hermann M Wolf
Journal:  J Clin Immunol       Date:  2014-09-10       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.